Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.79)
# 549
Out of 5,055 analysts
678
Total ratings
48.6%
Success rate
17.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine | Upgraded: Buy | $5 | $2.27 | +120.26% | 2 | Sep 23, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $106 → $86 | $55.14 | +55.97% | 9 | Sep 17, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $89 → $80 | $42.70 | +87.35% | 14 | Sep 14, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $40 → $44 | $30.02 | +46.57% | 4 | Sep 9, 2026 | |
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $50 | $20.77 | +140.73% | 1 | Aug 18, 2026 | |
| SPRB Spruce Biosciences | Reiterated: Buy | $123 → $104 | $38.98 | +166.80% | 2 | Aug 17, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $69 → $81 | $22.18 | +265.19% | 4 | Aug 11, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $43 → $35 | $14.90 | +134.90% | 6 | Aug 3, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $32.66 | $9.50 | +243.80% | 4 | Jul 9, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $51 | $37.02 | +37.76% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $11 | $4.23 | +160.05% | 5 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.29 | - | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.43 | - | 7 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.66 | - | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.32 | +201.72% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $17 | $4.55 | +273.63% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.10 | +290.24% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $2.01 | +994.53% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $6.03 | +215.09% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $20.01 | +124.89% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $330.69 | -14.12% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $5.47 | +375.75% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $26.23 | +121.12% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $2.63 | n/a | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $95 | $20.97 | n/a | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $16.83 | n/a | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $5 | $3.13 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 → $546 | $498.50 | n/a | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $55 | $23.65 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $15.04 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $50.22 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $224.47 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $24 | $3.51 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.1399 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $10.52 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.09 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $23.26 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | CHF 3.08 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $29.40 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $30 | $8.01 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $20.96 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.69 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $1.30 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.51 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $1.94 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $24.77 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $3.31 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $36.89 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $15.13 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $30.94 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $116.23 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $1.5 | $0.729 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $16.88 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 | $59.67 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.25175 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $11.12 | n/a | 13 | Aug 14, 2015 |
Editas Medicine
Sep 23, 2026
Upgraded: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
BioMarin Pharmaceutical
Sep 17, 2026
Reiterated: Buy
Price Target: $106 → $86
Current: $55.14
Upside: +55.97%
Ionis Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $89 → $80
Current: $42.70
Upside: +87.35%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $30.02
Upside: +46.57%
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $20.77
Upside: +140.73%
Spruce Biosciences
Aug 17, 2026
Reiterated: Buy
Price Target: $123 → $104
Current: $38.98
Upside: +166.80%
Neurogene
Aug 11, 2026
Reiterated: Buy
Price Target: $69 → $81
Current: $22.18
Upside: +265.19%
Ultragenyx Pharmaceutical
Aug 3, 2026
Reiterated: Buy
Price Target: $43 → $35
Current: $14.90
Upside: +134.90%
Satellos Bioscience Inc.
Jul 9, 2026
Reiterated: Buy
Price Target: $32.66
Current: $9.50
Upside: +243.80%
Edgewise Therapeutics
Jul 6, 2026
Reiterated: Buy
Price Target: $51
Current: $37.02
Upside: +37.76%
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $4.23
Upside: +160.05%
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $8.29
Upside: -
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $11.43
Upside: -
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.66
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.32
Upside: +201.72%
Jun 5, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $4.55
Upside: +273.63%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.10
Upside: +290.24%
Jun 2, 2026
Reiterated: Buy
Price Target: $22
Current: $2.01
Upside: +994.53%
May 28, 2026
Reiterated: Buy
Price Target: $19
Current: $6.03
Upside: +215.09%
May 7, 2026
Reiterated: Buy
Price Target: $45
Current: $20.01
Upside: +124.89%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $330.69
Upside: -14.12%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $5.47
Upside: +375.75%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $26.23
Upside: +121.12%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $2.63
Upside: n/a
Sep 24, 2025
Reiterated: Buy
Price Target: $28 → $95
Current: $20.97
Upside: n/a
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $16.83
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $20 → $5
Current: $3.13
Upside: n/a
Aug 6, 2025
Reiterated: Buy
Price Target: $450 → $546
Current: $498.50
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $78 → $55
Current: $23.65
Upside: n/a
Aug 14, 2024
Reiterated: Buy
Price Target: $45 → $50
Current: $15.04
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $50.22
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $224.47
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $28 → $24
Current: $3.51
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.1399
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $10.52
Upside: n/a
Sep 1, 2020
Reiterated: Buy
Price Target: $20
Current: $3.09
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $23.26
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: CHF 3.08
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $29.40
Upside: n/a
Aug 11, 2020
Reiterated: Buy
Price Target: $36 → $30
Current: $8.01
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $20.96
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $1.69
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $1.30
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $3.51
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $1.94
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $54
Current: $24.77
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $3.31
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $36.89
Upside: n/a
Dec 18, 2019
Reiterated: Buy
Price Target: $2
Current: $15.13
Upside: n/a
Aug 1, 2017
Reiterated: Hold
Price Target: n/a
Current: $30.94
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $116.23
Upside: n/a
Oct 20, 2016
Reiterated: Hold
Price Target: $9 → $1.5
Current: $0.729
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $16.88
Upside: n/a
Oct 16, 2015
Reiterated: Hold
Price Target: $63
Current: $59.67
Upside: n/a
Aug 16, 2015
Reiterated: Buy
Price Target: $4
Current: $0.25175
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $11.12
Upside: n/a